by Pharma blister packaging allows pharmaceutical manufacturer/companies to pack solid oral dosage forms of medicines like tablets, capsules, powders in single dose pack form ready for direct distribution and dispensing. Blister packaging provides various advantages like medication visibility, child-resistance feature, light weight, prevention of product contamination, and easy to handle packaging. The tamper-proof nature offered by blister packaging makes it the ideal pharmaceutical packaging solution.
The global Pharma Blister Packaging Market is estimated to be valued at US$ 11.03 Bn or Billion in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the pharma blister packaging market is the rising demand for innovative and patient-centric packaging designs. Manufacturers are focusing on designing intuitive, easy-to-use, and functional blister packs that can improve patient compliance and experience. Features like calendar blister packs, tear-off strip designs for easy access, and multi-compartment blister packs are gaining popularity. Improved child-resistant and senior-fri
endly blister designs are also being developed to meet the needs of different consumer groups. Another major trend is the increasing adoption of eco-friendly raw materials for blister pack manufacturing. Materials derived from renewable plant-based sources are being explored to develop more sustainable pharma packaging solutions.
Porter’s Analysis
- Threat of new entrants: Low barriers to entry in pharma blister packaging industry allows new players to easily enter the market. However, established players have strong brand recognition and supply chain which poses challenge for new entrants.
- Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power over suppliers due to their bulk purchase orders. Buyers can negotiate on price and demand value-added services to gain competitive advantages.
- Bargaining power of suppliers: A few large suppliers dominate the global blister packaging machinery and raw material supply. This enhances their bargaining power over packaging players. However, availability of substitutes keeps supplier power in check.
- Threat of new substitutes: Pharma strip packs and bottles are alternatives for primary product packaging but cannot match protection and ease-of-dispensing features of blister packs. Hence threat from substitutes is low.
- Competitive rivalry: Presence of numerous global and regional players leads to intense competition. Companies compete based on innovation, sustainability, and compliance with stringent regulatory norms.
Key Takeaways
The global Pharma Blister Packaging Market is expected to witness high growth, exhibiting CAGR of 5.0% over the forecast period, due to increasing need for tamper-evident and patient-compliance packaging.
Regional analysis: Asia Pacific dominates the global market and is expected to grow at fastest pace during forecast period supported by expanding pharmaceutical manufacturing in India and China. North America and Europe also capture sizable market shares.
Key players operating in the Pharma Blister Packaging are Amcor Plc, Wonderpack group, Bilcare Limited, Sonoco Products Company, Honeywell International Inc., ACG Pharmapack Pvt. Ltd., West Rock Company, Constantia Flexibles GmbH, WINPAK LTD, Rohrer Corporation, Accupack, Nirmala Industries, etc. Amcor and Constantia Flexibles have established strong market shares through acquisitions while emerging Asian players are exploring opportunities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
